Ablatherm Peer Reviewed Data Featured on Top Urology Reference Site
Ablatherm Peer Reviewed Data Featured on Top Urology Reference Site
Ablatherm Peer Reviewed Data Featured on Top Urology Reference Site
Ablatherm Peer Reviewed Data Featured on Top Urology Reference SiteEDAP and Ablatherm-HIFU were again featured in an email distributed by UroToday.com to more than 14,000 urologists advising them of the site's HIFU Resource Center. Urotoday.com, located at http://www.urotoday.com, is one of the top global destinations for up-to-date Urology information and the latest in clinical techniques.
The newsletter, excerpted below, contains direct links to peer-reviewed HIFU publications with a wealth of Ablatherm-HIFU background and clinical data, widely considered the most comprehensive and credible HIFU clinical base available in prostate cancer.
The newsletter, excerpted below, contains direct links to peer-reviewed HIFU publications with a wealth of Ablatherm-HIFU background and clinical data, widely considered the most comprehensive and credible HIFU clinical base available in prostate cancer.
![]() |
Also featured this week is a mini review from the January Edition of the British Journal of Urology International
|